Ambicom (ABHI) 10-Q 16 Jun 14 2014 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Apr. 30, 2014	Jun. 16, 2014
Document Information [Line Items]	'	'
Entity Registrant Name	'AMBICOM HOLDINGS, INC	'
Entity Central Index Key	'0001444310	'
Current Fiscal Year End Date	'--07-31	'
Entity Filer Category	'Smaller Reporting Company	'
Trading Symbol	'ABHI	'
Entity Common Stock, Shares Outstanding	'	26,061,287
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Apr-14	'
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2014	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Apr. 30, 2014	Jul. 31, 2013
Current assets:	'	'
Cash and cash equivalents	$249,212	$596,871
Accounts receivable, net of allowance for doubtful accounts of $26 and $26 as of April 30, 2014 and July 31, 2013, respectively	445,640	191,835
Inventory, net of reserve balances of $7,551 and $10,360 as of April 30, 2014 and July 31, 2013, respectively	72,556	89,732
Prepaid expenses and other current assets	85,406	167,274
Total current assets	852,814	1,045,712
Property and equipment, net	104,039	15,201
Deposit	20,695	20,695
Total assets	977,548	1,081,608
Current liabilities:	'	'
Accounts payable and accrued liabilities	69,167	39,077
Accounts payable - other	25,791	23,733
Deferred revenue	11,880	381,980
Notes payable - current portion	15,688	0
Total current liabilities	122,526	444,790
Notes payable, net of current	62,206	0
Total liabilities	184,732	444,790
Stockholders' equity:	'	'
Common stock, $0.008 par value; 125,000,000 shares authorized; 11,442,473 and 10,806,520 shares issued and outstanding at April 30, 2014 and July 31, 2013, respectively	91,537	86,449
Additional paid in capital	11,620,594	11,493,738
Accumulated deficit	-10,931,415	-10,952,519
Total stockholders' equity	792,816	636,818
Total liabilities and stockholders' equity	977,548	1,081,608
Series A Preferred Stock [Member]	'	'
Stockholders' equity:	'	'
Preferred stock	10,000	7,050
Series B Preferred Stock [Member]	'	'
Stockholders' equity:	'	'
Preferred stock	$2,100	$2,100

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Apr. 30, 2014	Jul. 31, 2013
Allowance for doubtful accounts (in dollars)	$26	$26
Inventory valuation reserve (in dollars)	$7,551	$10,360
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares authorized	125,000,000	125,000,000
Common stock, shares issued	11,442,473	11,442,473
Common stock, shares outstanding	10,806,520	10,806,520
Series A Preferred Stock [Member]	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	10,000,000	10,000,000
Preferred stock, shares outstanding	7,050,000	7,050,000
Series B Preferred Stock [Member]	'	'
Preferred stock, par value (in dollars per share)	$0.01	$0.01
Preferred stock, shares authorized	325,000	325,000
Preferred stock, shares issued	262,475	262,475
Preferred stock, shares outstanding	262,475	262,475

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Sales	$476,684	$698,570	$1,719,120	$2,331,492
Cost of sales	196,886	312,208	775,144	1,070,312
Gross profits	279,798	386,362	943,976	1,261,180
Operating Expenses	'	'	'	'
Depreciation	6,488	1,578	17,675	4,698
Professional fees	38,470	36,385	214,389	176,259
Selling and general expenses	221,386	261,804	689,117	692,686
Total operating expenses	266,344	299,767	921,181	873,643
Income from operations	13,454	86,595	22,795	387,537
Other income (expense)	'	'	'	'
Other income and expense, net	2,000	0	2,000	0
Interest income (expense), net	-785	1	-1,965	3
Net other income	1,215	1	35	3
Total income before income taxes	14,669	86,596	22,830	387,540
Income taxes	0	0	1,600	0
Net income	$14,669	$86,596	$21,230	$387,540
Net income per share - basic (in dollars per share)	$0.00	$0.01	$0.00	$0.04
Net income per share - diluted (in dollars per share)	$0.00	$0.01	$0.00	$0.02
Weighted average shares outstanding — basic (in shares)	11,382,377	10,806,520	11,099,146	10,366,195
Weighted average shares outstanding — diluted (in shares)	22,068,948	18,118,995	19,524,301	17,678,670

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Apr. 30, 2014	Apr. 30, 2013
Cash flows from operating activities:	'	'
Net income	$21,230	$387,540
Net income items not affecting cash:	'	'
Depreciation and amortization	17,675	4,698
Stock-based compensation	9,818	7,106
Issuance of stock to board member for advisory services	47,000	20,000
Issuance of stock to investment firm	50,000	0
Issuance of Preferred A stock to Officer	2,950	0
Increase in bad debt reserve	0	483
Increase in reserve for inventory loss	5,471	7,754
Increase / (Decrease) in operating assets:	'	'
Accounts receivable	-253,805	216,255
Inventory	11,706	89,296
Prepaid expense	81,868	-29,212
Decrease / (Increase) in operating liabilities:	'	'
Accounts payable - trade	45,434	28,211
Accrued payable - other	-13,286	-23,080
Unearned revenue	-370,100	-215,004
Net cash provided by (used in) operating activities	-344,039	494,047
Cash flows from investing activities:	'	'
Capital expenditures	-106,514	-1,075
Net cash used in investing activities	-106,514	-1,075
Cash flows from financing activities:	'	'
Proceeds from sale of common stock	25,000	0
Proceeds from notes payable	77,894	0
Payments on notes payable	0	-54,000
Net cash provided by (used in) financing activities	102,894	-54,000
Net increase (decrease) in cash and cash equivalents	-347,659	438,972
Cash and cash equivalents, beginning of period	596,871	249,327
Cash and cash equivalents, end of period	249,212	688,299
Supplemental information:	'	'
Income taxes paid	0	0
Interest paid	$1,965	$0

Organization_and_Principal_Act

Organization and Principal Activities	9 Months Ended
	Apr. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Nature of Operations [Text Block]	'
	NOTE 1 – Organization and Principal Activities
	AmbiCom Holdings, Inc. (“AmbiCom Holdings” or the ‘Company”) was incorporated as Med Control, Inc. (“Med Control”) under the laws of the State of Nevada on July 1, 2008. Med Control was a development stage enterprise until January 15, 2010. All of Med Control’s activities prior to January 15, 2010 related to its organization, initial funding and share issuances. On January 15, 2010, Med Control changed its name to AmbiCom Holdings, Inc.
	On January 15, 2010, Med Control, Inc. (the “Registrant”) authorized its Articles of Incorporation (the “Amendment”) to change its name to AmbiCom Holdings, Inc., to increase the number of its authorized shares of capital stock from 75,000,000 to 1,050,000,000 shares of which 1,000,000,000 were designated common stock and 50,000,000 were designated preferred stock, par value $0.001 per share (the “Preferred Stock”) and to effect a forward-split such that 131.2335958 shares of Common Stock were issued for every 1 share of Common Stock issued and outstanding immediately prior to filing of the amendment (the “Forward Split”).
	On January 15, 2010, the Company acquired AmbiCom Acquisition Corp. a privately owned Nevada corporation (“AmbiCom”), pursuant to an Agreement and Plan of Share Exchange (the “Exchange”). AmbiCom was organized under the laws of the State of Nevada on July 29, 2008. AmbiCom is a holding company whose operating company, AmbiCom, Inc., is a designer and developer of wireless products focusing on the wireless medical industry. AmbiCom’s wireless modules and devices are based on its innovative application software and Wi-Fi or Bluetooth technologies.
	Pursuant to the terms of the Exchange, the Company acquired AmbiCom from the AmbiCom equity holders in exchange for an aggregate of 20,000,000 newly issued shares of Common Stock, 2,600,000 shares of Series B Preferred Stock, an option to purchase 5,500,000 shares of Common Stock and 2,350,000 shares of Series A Preferred Stock at the purchase price of $0.01 per share, and warrants to purchase 500,000 shares of Common Stock at the exercise price of $0.50 per share (collectively, the “Exchange Shares”). As a result of the Exchange, the AmbiCom equity holders surrendered all of their issued and outstanding capital stock of AmbiCom in consideration for the Exchange Shares and AmbiCom became a wholly-owned subsidiary of the Company.
	Simultaneously upon the Closing, the Company closed an offering (the “Offering”) of its Common Stock at a price of $0.40 per share for an aggregate of 1,250,000 shares of Common Stock for aggregate offering price of $500,000.
	In addition, contemporaneously with the Closing, the Company and its former principal stockholder, Ms. Kato, split-off its wholly owned subsidiary, MCI Acquisition Corp., a newly-formed Nevada corporation (“MCAC”), whereby the Company assigned all of its previous operating assets to MCAC in consideration for the assumption of all of the Company’s liabilities to Ms. Kato, who is currently the principal shareholder of MCI and the retirement and cancellation of Ms. Kato’s 6,000,000 shares of Common Stock pursuant to the terms and conditions of a split-off agreement by and among the Company, Ms. Kato, and MCAC (the “Split-Off Agreement”).
	Following the issuance of the Exchange Shares and the retirement of Ms. Kato’s shares pursuant to the Split-Off Agreement, the former stockholders of AmbiCom and/or their designees now beneficially own approximately fifty-five percent (55%) of the total outstanding shares of Common Stock, and after giving effect to the conversion of the Series B in accordance with their respective terms (and the satisfaction of certain conditions to the conversion of such shares) seventy-six percent (76%) of the total outstanding shares of Common Stock on a fully-diluted basis.
	Details of the Company’s subsidiary as of April 30, 2014 are as follows:
	Name	Place and Date of	Relationships	Principal Activities
		Establishment/
		Incorporation
	E-Care USA, Inc.	Nevada	Wholly-owned subsidiary of AmbiCom Holdings, Inc.	Designer and developer of wireless home medical devices
		15-Mar-11
	Inter-company accounts and transactions have been eliminated in consolidation.

Basis_of_Presentation

Basis of Presentation	9 Months Ended
	Apr. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Basis of Accounting [Text Block]	'
	NOTE 2 – Basis of Presentation
	The accompanying consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and accounting principles generally accepted in the United States for financial information. The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. Significant estimates made in preparing the financial statements include revenue recognition and costs of revenue, inventory valuations, long-lived and intangible asset valuations and loss contingencies. In the opinion of management, the financial statements include all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of the periods presented.
	For financial accounting purposes, the acquisition was a reverse acquisition of the Company by AmbiCom, under the purchase method of accounting, and was treated as a recapitalization with AmbiCom as the acquirer.  Upon consummation of the Exchange, the Company adopted the business plan of AmbiCom.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Apr. 30, 2014
Accounting Policies [Abstract]	'
Business Description and Accounting Policies [Text Block]	'
	NOTE 3 – Summary of Significant Accounting Policies
	The summary of significant accounting policies is presented to assist in understanding the Company’s financial statements. These accounting policies conform to generally accepted accounting principles and have been consistently applied in the preparation of the financial statements.
	a) Description of Business - The Company is a leading designer and developer of wireless technologies which emphasize wireless medical and other wireless products.
	b) Segment Information - The Company follows ASC Topic 280, “Disclosures about Segments of an Enterprise and Related Information.” Topic 280 requires that a company report financial and descriptive information about its reportable operating segments. Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker currently evaluates the Company’s operations from a number of different operational perspectives including but not limited to a client by client basis. The Company derives all significant revenues from a single reportable operating segment of business. Accordingly, the Company does not report more than one segment; nevertheless, management evaluates, at least annually, whether the Company continues to have one single reportable segment.
	c) Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates, and the differences may be material to the financial statements. Estimates are used primarily in determining the depreciable lives of fixed assets, and inventory valuation. In addition, estimates form the basis for the reserves for sales allowances, accounts receivable and inventory. Various assumptions go into the determination of these estimates. The process of determining significant estimates requires consideration of factors such as historical experience and current and expected economic conditions.
	d) Cash and Cash Equivalents - The Company considers all highly liquid investments and time deposits with original maturities of three months or less when purchased to be cash equivalents. All cash and cash equivalents are maintained with nationally recognized financial institutions.
	e) Allowance for Doubtful Accounts - An allowance for doubtful accounts is computed based on the Company’s historical experience and management’s analysis of possible bad debts. Accounts receivable are shown net of an allowance for doubtful accounts of $26 as of April 30, 2014 and $26 as of July 31, 2013, respectively.
	f) Inventories - Inventories are stated at the lower of cost or market on an average basis. Inventory reserves are recorded for damaged, obsolete, excess and slow-moving inventory. Market value of inventory is estimated based on the impact of market trends, an evaluation of economic conditions and the value of current orders relating to the future sales of this type of inventory. As of April 30, 2014 and July 31, 2013, the value of the inventory reserve was $7,551 and $10,360, respectively.
	g) Income Taxes - The Company accounts for income taxes pursuant to the FASB ASC Topic 740, "Accounting for Uncertainty in Income Taxes", (“Topic 740”). Topic 740 clarifies the accounting for uncertainty in income taxes recognized in the Company’s financial statements in accordance with generally accepted accounting principles. The calculation of the Company's tax provision involves the application of complex tax rules and regulations within multiple jurisdictions. The Company's tax liabilities include estimates for all income-related taxes that the Company believes are probable and that can be reasonably estimated. To the extent that the Company’s estimates are understated, additional charges to the provision for income taxes would be recorded in the period in which the Company determines such understatement. If the Company's income tax estimates are overstated, income tax benefits will be recognized when realized. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Topic 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
	h) Revenue Recognition - The majority of the Company's product revenues are recognized upon shipment or delivery and acceptance of products by customers, when pervasive evidence of a sales arrangement exists, the price is fixed or determinable, the title has transferred and collection of resulting receivables is reasonably assured. For merchandise products, the Company recognizes revenue upon shipment of products, when title is passed and the amount collectible can reasonably be determined. All amounts billed to a customer related to shipping and handling are classified as revenue, while all costs incurred by the Company for shipping and handling are classified as selling expenses. For NRE projects, revenue is recognized for the deliverable portions that meet the revenue recognition criteria that persuasive evidence that an agreement exists, delivery has occurred or services have been rendered, the price is fixed and determinable, and collectability is reasonably assured.
	i) Research and Development Costs - Research and development costs are expensed as incurred.
	j) Stock-Based Compensation - The Company adopted ASC Topic 718 “Share-Based Payment”. As permitted, the Company elected to adopt disclosure-only provisions of ASC Topic 718 in accordance with generally accepted accounting principles. Under the provisions of Topic ASC 718, compensation expense is recognized based on the fair value of options on the grant date.
	k) Fair Value of Financial Instruments - ASC Topic 820, “Fair Value Measurements”, requires disclosure of the level within the fair value hierarchy in which fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). The Company's financial instruments consist of cash and cash equivalents, short-term trade receivables and payables at April 30, 2014.
	Fair Value of Financial Instruments
	The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments at:
		April 30, 2014				July 31, 2013
		Carrying		Fair value		Carrying		Fair value
		amount				amount
	Financial assets:
	Cash and cash equivalents	$	249,212	$	249,212	$	596,871	$	596,871
	Accounts receivable	$	445,640	$	445,640	$	191,835	$	191,835
	Financial liabilities:
	Accounts payable and accrued liabilities	$	94,958	$	94,958	$	62,810	$	62,810
	Auto loan	$	77,894	$	71,651		0		0
	The fair values of the financial instruments shown in the above table represent the amounts that would be received when those assets are sold or that would be paid when those liabilities are transferred in an orderly transaction between market participants at the measurement date. Those fair value measurements maximize the use of observable inputs.
	However, in situations where there is little, if any, market activity for the asset or liability at the measurement date, the fair value measurement reflects the Company’s own judgments about the assumptions that market participants would use in pricing the asset or liability. Those judgments are developed by the Company based on the best information available in the circumstances, including expected cash flows and appropriately risk-adjusted discount rates, available observable and unobservable inputs.
	The Company uses the following methods and assumptions in estimating the fair value disclosures for financial instruments:
	Cash equivalents
	The carrying amount reported in the balance sheets of cash equivalents approximate fair value because of the relatively short time to maturity.
	Accounts receivable
	The carrying amount reported in the balance sheets of accounts receivable approximate fair value because of the relatively short time to maturity.
	Accounts payable and accrued liabilities
	The carrying amount reported in the balance sheets of accrued payable and accrued liabilities approximate fair value because of the relatively short time to maturity.
	Notes payable
	The fair value of the Company’s notes payable are measured using quoted offer-side prices when quoted market prices are available. If quoted market prices are not available, the fair value is determined by discounting the future cash flows of each instrument at rates that reflect rates currently observed in publicly traded debt markets for debt of similar terms to companies with comparable credit risk. For long-term debt measurements, where there are no rates currently observable in publicly traded debt markets of similar terms with comparable credit, the Company uses market interest rates and adjusts that rate for all necessary risks, including its own credit risk.
	Fair Value Hierarchy
	The following table presents the placement in the fair value hierarchy of assets and liabilities that are measured at fair value on a recurring basis at:
				Fair value measurements at
				reporting date using
		April 30,		Quoted prices		Significant		Significant
		2014		in active		other		unobservable
				markets for		observable		inputs
				identical		inputs		(Level 3)
				assets		(Level 2)
				(Level 1)
	Notes payable	77,894						71,650
				Fair value measurements at
				reporting date using
		31-Jul-13		Quoted prices		Significant		Significant
				in active		other		unobservable
				markets for		observable		inputs
				identical		inputs		(Level 3)
				assets		(Level 2)
				(Level 1)
	Notes payable	0						0
	l) Translation of Foreign Currency - The Company accounts for its foreign operations in accordance with ASC Topic 830, “Foreign Currency Translation”. For the branch, non-monetary balance sheet items and related income statements items are translated at historical exchange rates, while monetary balance sheet items are translated at current exchange rates. Income statement items, other than monetary, are translated at the weighted average exchange rate during the year. Deferred taxes are not provided on translation gains and losses where the Company expects earnings of a foreign branch to be permanently reinvested.
	m) Concentration - Financial instruments which potentially subject the Company to concentrations of credit risk are primarily accounts receivable. The Company performs ongoing credit evaluations of its customers’ financial condition. If the collection of the receivable becomes doubtful, the Company establishes a reserve in an amount determined appropriate for the perceived risk. The Company maintains its cash accounts at commercial banks. From time to time, cash balances maintained in such banks may exceed the insured amount by the Federal Deposit Insurance Corporation (FDIC). As of April 30, 2014 and July 31, 2013, management does not believe they are exposed to any significant risk on their cash balances. The Company’s products are primarily sold to global medical device companies. These customers can be significantly affected by changes in economic, competitive or other factors. The Company makes substantial sales to a relatively few, large customers, where company is seeking to capture more business from other targeted medical device companies.
	Two customers accounted for $294,000 (66%) and $150,000 (34%) of receivables at April 30, 2014 while one customer accounted for $190,000 (99%) of receivables at July 31, 2013.
	Two customers accounted for $294,000 (62%) and $150,000 (31%) of revenue for the three months ended April 30, 2014 and two customers accounted for $418,000 (60%) and $198,000 (28%) of revenue for the three months ended April 30, 2013. Three customers accounted for $1,070,200 (62%), $206,250 (12%), and $184,995 (11%) of the revenues for the nine months ended April 30, 2014 and two customers accounted for $1,428,724 (61%) and $300,000 (13%) of the revenues for the nine months ended April 30, 2013, respectively.
	Two vendors accounted for $52,000 (75%) and $8,791 (13%) of accounts payable as of April 30, 2014 and three vendors accounted for $20,000 (53%), $5,054 (13%), and $4,400 (12%) of accounts payable as of July 31, 2013, respectively.
	One vendor accounted for $178,360 (97%) of the purchases for the three months ended April 30, 2014, and three vendors accounted for $158,485 (52%), $83,800 (28%), and $47,200 (16%) of the purchases for the three months ended April 30, 2013. One vendor accounted for $708,927 (95%) of the purchases for the nine months ended April 30, 2014, and one vendor accounted for $839,209 (83%) of the purchases for the nine months ended April 30, 2013, respectively.
	RECENT ACCOUNTING PRONOUNCEMENTS
	FASB ASC Topic 220, “Compressive Income” - New authoritative accounting guidance under ASC Topic 220, “Compressive Income,” amends prior guidance to require all non-owner changes in stockholders' equity to be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Under the two-statement approach, the first statement should present total net income and its components followed consecutively by a second statement that should present total other comprehensive income, the components of other comprehensive income, and the total of comprehensive income. The pronouncement should be applied retrospectively and effective for fiscal years, and interim periods within those years, beginning after December 15, 2012. Early adoption is permitted. The adoption of this pronouncement is not expected to have a material impact on the Company's financial statements.
FASB ASC Topic 350, “Intangible and Other Assets” - New authoritative accounting guidance under ASC Topic 350, “Intangible and Other Assets,”, which allows for an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. Under new guidance, an entity is not required to calculate the fair value of a reporting unit unless the entity determines that it is more likely than not that its fair value is less than its carrying amount. The pronouncement is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted. The adoption of this pronouncement is not expected to have a material impact on the Company's financial statements.
Management does not believe that any other recently issued but not yet effective accounting pronouncements, if adopted, would have an effect on the accompanying consolidated financial statements.

Liquidity_and_Shareholders_Equ

Liquidity and Shareholders' Equity	9 Months Ended
	Apr. 30, 2014
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	NOTE 4 – Liquidity and Shareholders’ Equity
	Cash and cash equivalents were $249,212 and $596,871 at April 30, 2014 and July 31, 2013, respectively. Our working capital was a positive balance of $730,288 and a positive balance of $600,922 at April 30, 2014 and July 31, 2013, respectively.
	Preferred Stock
	The Company's Amended Articles of Incorporation authorizes the issuance of 50,000,000 shares of Preferred Stock, par value $0.001 per share, subject to any limitations prescribed by law, without further vote or action by the stockholders, to issue from time to time shares of preferred stock in one or more series. Each such series of Preferred Stock shall have such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges as shall be determined by the Company's board of directors, which may include, among others, dividend rights, voting rights, liquidation preferences, conversion rights and preemptive rights.
	Series A Convertible Preferred Stock
	The Company has authorized a total of 10,000,000 shares of Series A Convertible Preferred Stock (the “Series A”).  The Series A is convertible at any time into shares of the Company’s common stock at the conversion rate of one share of Common Stock per each share of Series A converted.  The Series A is treated on an “as converted” basis for both voting and liquidation rights. For the year-ended July 31, 2013, 7,050,000 shares of Series A were issued and outstanding. There are currently 10,000,000 shares of Series A outstanding as of April 30, 2014. In June 2011, an amendment was filed with the Secretary of State of Nevada whereby the conversion price of Series A would remain unchanged in event of stock split, stock dividend on the common stock, a reclassification of the common stock or distribution to holders of common stock. If the Company reports net income in two of the following four years following the Exchange, the Series A shall be convertible into Common Stock at the conversion rate of two shares of Common Stock per each share of Series A converted. In December 2013, an amendment was filed with the Secretary of State of Nevada whereby the total of Series A Convertible Preferred Shares authorized increased to 10,000,000 shares.
	Series B Convertible Preferred Stock
	In September 2011, the Company Amended and Restated its Articles of Incorporation. Before the amendment, there were 2,600,000 shares of Series B Convertible Preferred Stock outstanding at $0.001 par value per share as of July 31, 2011. After the amendment, there were 325,000 shares of Series B Convertible Preferred Stock outstanding at $0.008 par value per share as of July 31, 2011.
	For the year-ended July 31, 2013, there were 262,475 shares of Series B Convertible Preferred Stock outstanding. There are currently 262,475 shares of Series B outstanding as of April 30, 2014.
	The Series B accrues annual dividends at the rate of 6% per year in shares of Common Stock at the dividend conversion rate of $1.00.  The Series B, together with any unpaid dividends, is convertible at any time into shares of the Company’s common stock at the conversion rate of one share of Common Stock per each share of Series B converted.  Following the second anniversary of the Exchange, the Series B, together with any unpaid dividends, shall be convertible into Common Stock at the conversion price of forty cents ($0.40) or seventy percent (70%) of the daily volume weighted average price of the Common Stock for the twenty trading days immediately prior to the conversion.  The Series B is redeemable by the Company, at any time prior to December 31, 2015, in cash at the redemption rate of $1.00 per share of Series B plus any accrued and unpaid dividends.  On December 31, 2015, all outstanding shares of Series B shall be redeemed by the Company at a per share redemption price equal to $1.00 per share of Series B plus an amount of Common Stock equal to the amount of the accrued and unpaid dividend thereon.  The Series B has a liquidation preference of $2,600,000 and ranks prior to the Series A and the Common Stock.  The Series B votes on an “as converted” basis.
	Options
	As of April 30, 2014, there were options issued and outstanding for the purchases of 343,000 shares of Common Stock.
	2010 Equity Incentive Plan
	On January 15, 2010, our Board and Stockholders approved and adopted the 2010 Equity Incentive Plan (the “2010 Plan”). A copy of the 2010 Plan was attached as Exhibit 10.4 to Form 8-K filed with the Securities and Exchange Commission on January 22, 2010.
	The 2010 Plan is intended to promote the interests of the Company by attracting and retaining exceptional employees, consultants, directors, officers and independent contractors (collectively referred to as the “Participants”), and enabling such Participants to participate in the long-term growth and financial success of the Company. Under the 2010 Plan, the Company may grant stock options, which are intended to qualify as “incentive stock options” under Section 422 of the Internal Revenue Code of 1986, as amended (the “Incentive Stock Options”), non-qualified stock options (the “Nonqualified Stock Options”), stock appreciation rights (“SARs”) and restricted stock awards (the “Restricted Stock Awards”), which are restricted shares of Common Stock (the Incentive Stock Options, the Nonqualified Stock Options, the SARs and the Restricted Stock Awards are collectively referred to as “Incentive Awards”). Incentive Awards may be granted pursuant to the 2010 Plan for 10 years from the Effective Date.
	From time to time, the Company may issue Incentive Awards pursuant to the 2010 Plan.  Each of the awards will be evidenced by and issued under a written agreement. In accordance with the rules of the plan, the exercise price of options granted shall be not less than 110% of the average of the closing price for the 30 days preceding the grant date.
	The Board reserved a total of 2,277,778 shares of our Common Stock for issuance under the 2010 Plan. If an incentive award granted under the 2010 Plan expires, terminates, is unexercised or is forfeited, or if any shares are surrendered to us in connection with an incentive award, the shares subject to such award and the surrendered shares will become available for further awards under the Plan.
	The number of shares subject to the 2010 Plan, any number of shares subject to any numerical limit in the 2010 Plan, and the number of shares and terms of any Incentive Award may be adjusted in the event of any change in our outstanding Common Stock by reason of any stock dividend, spin-off, stock split, reverse stock split, recapitalization, reclassification, merger, consolidation, liquidation, business combination or exchange of shares, or similar transaction.
	On September 1, 2010, 840,000 options were granted to eight employees at an exercise price of $0.20 per share. By using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 1.79%; volatility of 40%; expected life of 10 years; and, all option grants without payment of dividends, the Company recognized a non-cash stock compensation charge for the three months ended April 30, 2014 and $446 for the nine months ended April 30, 2014 in connection with the issuance and vesting of these options.
	On May 1, 2012, 250,000 options were granted to two employees at an exercise price of $0.09 per share. By using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 1.79%; volatility of 40%; expected life of 10 years; and, all option grants without payment of dividends, the Company recognized a non-cash stock compensation charge of $732 for the three months ended April 30, 2014 and $2,196 for the nine months ended April 30, 2014 in connection with the issuance and vesting of these options.
	On September 1, 2012, 75,000 options were granted to two employees at an exercise price of $0.03 per share. By using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 1.59%; volatility of 67%; expected life of 10 years; and all option grants without payment of dividends, the Company recognized a non-cash stock compensation charge of $381 for the three months ended April 30, 2014 and $1,144 for the nine months ended April 30, 2014 in connection with the issuance and vesting of these options.
	On January 15, 2014, 305,000 options were granted to four employees at an exercise price of $0.16 per share. By using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 2.87%; volatility of 72%; expected life of 10 years; and, all option grants without payment of dividends, the Company recognized a non-cash stock compensation charge of $4,524 for the three months ended April 30, 2014 and $6,032 for the nine months ended April 30, 2014 in connection with the issuance and vesting of these options. At April 30, 2014, 807,778 options remain available for future grant under the Plan.
	As of April 30, 2014, there were options outstanding under the 2010 Plan to purchase 250,000 shares of Common Stock at a purchase price of $0.20 per share, 250,000 shares of Common Stock at a purchase price of $0.09 per share, 75,000 shares of Common Stock at a purchase price of $0.03 per share and 305,000 shares of Common Stock at a purchase price of $0.16 per share.
	Common Stock
	In September 2011, the Company Amended and Restated its Articles of Incorporation decreasing authorized shares for issuance from 1,000,000,000 shares of common stock, $0.001 par value per share to 125,000,000 shares of common stock, $0.008 par value per share. Before the amendment, there were 52,577,445 shares outstanding as of July 31, 2011. After the amendment, there were 11,442,473 shares and 10,806,520 shares outstanding as of April 30, 2014 and July 31, 2013, respectively.

Property_and_Equipment

Property and Equipment	9 Months Ended
	Apr. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	NOTE 5 – Property and Equipment
	Property and equipment are stated at cost. Depreciation is calculated using the straight-line method over the following estimated useful lives of the assets: furniture and fixtures –seven years; machinery and equipment –five years; software – five years; leasehold improvements –the life of the current facility lease. Major additions and betterments are capitalized and repairs and maintenance are charged to operations in the period incurred. Depreciation expense for the three months ended April 30, 2014 and 2013 were $6,488 and $1,578, respectively. Depreciation expense for the nine months ended April 30, 2014 and 2013 were $17,675 and $4,698, respectively.
		April 30, 2014		July 31, 2013
	Furniture and fixture	$	27,634	$	27,634
	Machinery and equipment		27,540		26,305
	Software		359,417		359,417
	Leasehold Improvements		5,985		5,985
	Vehicle		105,278		-
			525,854		419,341
	Accumulated depreciation		-421,815		-404,140
	Property and equipment, net	$	104,039	$	15,201

Revolving_Line_of_Credit

Revolving Line of Credit	9 Months Ended
	Apr. 30, 2014
Debt Disclosure [Abstract]	'
Revolving Line of Credit [Text Block]	'
	NOTE 6 – Revolving Line of Credit
	On May 9, 2011, advances under the credit line were secured with substantially all of the Company’s assets, were subject to interest at 1% above the Wall Street Journal prime rate index, and were subject to the following restrictive covenants: (i) the current ratio shall not be less than 1.2 times; (ii) the debt to tangible net worth ratio shall not exceed 2.5 times; and (iii) the quarterly EBITDA shall not be less than $30,000 on a rolling four quarter basis.
	As of July 2013, the Company chose not to renew this credit line and did not have a balance as of April 30, 2014.

Note_Payable

Note Payable	9 Months Ended
	Apr. 30, 2014
Debt Disclosure [Abstract]	'
Notes Payable [Text Block]	'
	NOTE 7 - Note Payable
	Note payable, which is unsecured, consists of the following as of April 30, 2014 and July 31, 2013:
	Note Payable Consist of the Following at:
		April 30, 2014		July 31, 2013
	Note payable to Bank of America, Auto Loan	$	77,894	$	-
	Total note payable		77,894		-
	Less current portion		15,688
	Long-term note payable	$	62,206	$	-

Income_Taxes

Income Taxes	9 Months Ended
	Apr. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	NOTE 8 – Income Taxes
	The consolidated income tax expense for the 6 months ended April 30, 2014 and 2013 was determined based upon estimates of the Company’s consolidated effective income tax rates for the years ending July 31, 2014 and 2013, respectively. The difference between the consolidated effective income tax rate and the U.S. federal statutory rate is primarily attributable to state income taxes, and the effect of certain permanent differences.
	FASB Topic 740, Accounting for Uncertainty in Income Taxes, prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Generally accepted accounting principles require that the Company recognizes in the financial statements a liability for tax uncertainty if it is more likely than not that the position will be sustained on an audit, based on the technical merits of the position. They also provide guidance on de-recognition, classification, interest and penalties, accounting in interim periods and disclosure. The Company has not recorded any liability for unrecognized tax benefits as of April 30, 2014. There have been no material changes in unrecognized tax benefits at April 30, 2014.
	The Company’s tax returns are subject to examination by federal, state and foreign taxing authorities. As of April 30, 2014, the statute of limitations for examining the Company’s federal income tax returns has not expired for the years ended July 31, 2010 through 2012. As of April 30, 2014, the statutes of limitation for tax examinations in the state of California have not expired for tax returns filed for the years ended July 31, 2009 through 2012.
	The Company did not make any provision for income taxes in the three months ended April 30, 2014. Our effective tax rate take into consideration federal and state minimum tax rates, foreign taxes and net operating loss (“NOL”) carry-forwards.
	The Company has accumulated NOLs of $2.16 million, which, if unutilized, will begin to expire in 2018. Future tax benefits, which may arise as a result of these losses, have not been recognized in these financial statements, and have been offset by a valuation allowance since there is no assurance that we will be able to utilize these NOLs.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Apr. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	NOTE 9 – Commitments and Contingencies
	The Company leases its office and warehouse. The Company signed a new lease for its office and warehouse effective March 1, 2011 at a new location. The maturity date for the lease is May 2016. The minimum rental commitments under the lease are as follows:
	Year Ending July 31:
	2014	$	14,352
	2015		58,007
	2016		49,537
	Total	$	121,896
	The rent expense for the three months ended April 30, 2014 and 2013 was $13,419 and $13,419, respectively. The rent expense for the nine months ended April 30, 2014 and 2013 was $40,256 and $40,256, respectively.

Subsequent_Events

Subsequent Events	9 Months Ended
	Apr. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	NOTE 10 – Subsequent Events
	Management has evaluated all events that occurred after the balance sheet date through the date when these financial statements were issued to determine if they must be reported. The management of the Company has determined that there was a reportable subsequent event to be disclosed as follows:
	On May 1, 2014 (the “Effective Date”), the Company executed an Asset Purchase Agreement with Veloxum Corp., a Delaware corporation (“Veloxum”) to acquire all of Veloxum’s assets for hares of the Company’s common stock, par value $0.008 per share (the “Common Stock”), equal to three million dollars ($3,000,000) calculated based on the average closing price of the Common Stock during the thirty (30) trading days preceding February 25, 2014. On May 29, 2014, the Company consummated the closing of the acquisition (the “Closing”) and issued 13,100,437 shares of Common Stock to Veloxum (the “Issuance”). In connection with the Closing, Veloxum’s former CEO and co-founder, Kevin Cornell, was appointed as the President of the Company. and Veloxum’s CTO and co-founder, Michael Lazar, was appointed its CTO.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Apr. 30, 2014
Accounting Policies [Abstract]	'
Description of Business [Policy Text Block]	'
	a) Description of Business - The Company is a leading designer and developer of wireless technologies which emphasize wireless medical and other wireless products.
Segment Reporting, Policy [Policy Text Block]	'
	b) Segment Information - The Company follows ASC Topic 280, “Disclosures about Segments of an Enterprise and Related Information.” Topic 280 requires that a company report financial and descriptive information about its reportable operating segments. Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker currently evaluates the Company’s operations from a number of different operational perspectives including but not limited to a client by client basis. The Company derives all significant revenues from a single reportable operating segment of business. Accordingly, the Company does not report more than one segment; nevertheless, management evaluates, at least annually, whether the Company continues to have one single reportable segment.
Use of Estimates, Policy [Policy Text Block]	'
	c) Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates, and the differences may be material to the financial statements. Estimates are used primarily in determining the depreciable lives of fixed assets, and inventory valuation. In addition, estimates form the basis for the reserves for sales allowances, accounts receivable and inventory. Various assumptions go into the determination of these estimates. The process of determining significant estimates requires consideration of factors such as historical experience and current and expected economic conditions.
Cash and Cash Equivalents, Policy [Policy Text Block]	'
	d) Cash and Cash Equivalents - The Company considers all highly liquid investments and time deposits with original maturities of three months or less when purchased to be cash equivalents. All cash and cash equivalents are maintained with nationally recognized financial institutions.
Allowance for Doubtful Accounts [Policy Text Block]	'
	e) Allowance for Doubtful Accounts - An allowance for doubtful accounts is computed based on the Company’s historical experience and management’s analysis of possible bad debts. Accounts receivable are shown net of an allowance for doubtful accounts of $26 as of April 30, 2014 and $26 as of July 31, 2013, respectively.
Inventory, Policy [Policy Text Block]	'
	f) Inventories - Inventories are stated at the lower of cost or market on an average basis. Inventory reserves are recorded for damaged, obsolete, excess and slow-moving inventory. Market value of inventory is estimated based on the impact of market trends, an evaluation of economic conditions and the value of current orders relating to the future sales of this type of inventory. As of April 30, 2014 and July 31, 2013, the value of the inventory reserve was $7,551 and $10,360, respectively.
Income Tax, Policy [Policy Text Block]	'
	g) Income Taxes - The Company accounts for income taxes pursuant to the FASB ASC Topic 740, "Accounting for Uncertainty in Income Taxes", (“Topic 740”). Topic 740 clarifies the accounting for uncertainty in income taxes recognized in the Company’s financial statements in accordance with generally accepted accounting principles. The calculation of the Company's tax provision involves the application of complex tax rules and regulations within multiple jurisdictions. The Company's tax liabilities include estimates for all income-related taxes that the Company believes are probable and that can be reasonably estimated. To the extent that the Company’s estimates are understated, additional charges to the provision for income taxes would be recorded in the period in which the Company determines such understatement. If the Company's income tax estimates are overstated, income tax benefits will be recognized when realized. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Topic 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
Revenue Recognition, Policy [Policy Text Block]	'
	h) Revenue Recognition - The majority of the Company's product revenues are recognized upon shipment or delivery and acceptance of products by customers, when pervasive evidence of a sales arrangement exists, the price is fixed or determinable, the title has transferred and collection of resulting receivables is reasonably assured. For merchandise products, the Company recognizes revenue upon shipment of products, when title is passed and the amount collectible can reasonably be determined. All amounts billed to a customer related to shipping and handling are classified as revenue, while all costs incurred by the Company for shipping and handling are classified as selling expenses. For NRE projects, revenue is recognized for the deliverable portions that meet the revenue recognition criteria that persuasive evidence that an agreement exists, delivery has occurred or services have been rendered, the price is fixed and determinable, and collectability is reasonably assured.
Research and Development Expense, Policy [Policy Text Block]	'
	i) Research and Development Costs - Research and development costs are expensed as incurred.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	j) Stock-Based Compensation - The Company adopted ASC Topic 718 “Share-Based Payment”. As permitted, the Company elected to adopt disclosure-only provisions of ASC Topic 718 in accordance with generally accepted accounting principles. Under the provisions of Topic ASC 718, compensation expense is recognized based on the fair value of options on the grant date.
Fair Value of Financial Instruments, Policy [Policy Text Block]	'
	k) Fair Value of Financial Instruments - ASC Topic 820, “Fair Value Measurements”, requires disclosure of the level within the fair value hierarchy in which fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). The Company's financial instruments consist of cash and cash equivalents, short-term trade receivables and payables at April 30, 2014.
	Fair Value of Financial Instruments
	The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments at:
		April 30, 2014				July 31, 2013
		Carrying		Fair value		Carrying		Fair value
		amount				amount
	Financial assets:
	Cash and cash equivalents	$	249,212	$	249,212	$	596,871	$	596,871
	Accounts receivable	$	445,640	$	445,640	$	191,835	$	191,835
	Financial liabilities:
	Accounts payable and accrued liabilities	$	94,958	$	94,958	$	62,810	$	62,810
	Auto loan	$	77,894	$	71,651		0		0
	The fair values of the financial instruments shown in the above table represent the amounts that would be received when those assets are sold or that would be paid when those liabilities are transferred in an orderly transaction between market participants at the measurement date. Those fair value measurements maximize the use of observable inputs.
	However, in situations where there is little, if any, market activity for the asset or liability at the measurement date, the fair value measurement reflects the Company’s own judgments about the assumptions that market participants would use in pricing the asset or liability. Those judgments are developed by the Company based on the best information available in the circumstances, including expected cash flows and appropriately risk-adjusted discount rates, available observable and unobservable inputs.
	The Company uses the following methods and assumptions in estimating the fair value disclosures for financial instruments:
	Cash equivalents
	The carrying amount reported in the balance sheets of cash equivalents approximate fair value because of the relatively short time to maturity.
	Accounts receivable
	The carrying amount reported in the balance sheets of accounts receivable approximate fair value because of the relatively short time to maturity.
	Accounts payable and accrued liabilities
	The carrying amount reported in the balance sheets of accrued payable and accrued liabilities approximate fair value because of the relatively short time to maturity.
	Notes payable
	The fair value of the Company’s notes payable are measured using quoted offer-side prices when quoted market prices are available. If quoted market prices are not available, the fair value is determined by discounting the future cash flows of each instrument at rates that reflect rates currently observed in publicly traded debt markets for debt of similar terms to companies with comparable credit risk. For long-term debt measurements, where there are no rates currently observable in publicly traded debt markets of similar terms with comparable credit, the Company uses market interest rates and adjusts that rate for all necessary risks, including its own credit risk.
	Fair Value Hierarchy
	The following table presents the placement in the fair value hierarchy of assets and liabilities that are measured at fair value on a recurring basis at:
				Fair value measurements at
				reporting date using
		April 30,		Quoted prices		Significant		Significant
		2014		in active		other		unobservable
				markets for		observable		inputs
				identical		inputs		(Level 3)
				assets		(Level 2)
				(Level 1)
	Notes payable	77,894						71,650
				Fair value measurements at
				reporting date using
		31-Jul-13		Quoted prices		Significant		Significant
				in active		other		unobservable
				markets for		observable		inputs
				identical		inputs		(Level 3)
				assets		(Level 2)
				(Level 1)
	Notes payable	0						0
Foreign Currency Transactions and Translations Policy [Policy Text Block]	'
	l) Translation of Foreign Currency - The Company accounts for its foreign operations in accordance with ASC Topic 830, “Foreign Currency Translation”. For the branch, non-monetary balance sheet items and related income statements items are translated at historical exchange rates, while monetary balance sheet items are translated at current exchange rates. Income statement items, other than monetary, are translated at the weighted average exchange rate during the year. Deferred taxes are not provided on translation gains and losses where the Company expects earnings of a foreign branch to be permanently reinvested.
Concentration [Policy Text Block]	'
	m) Concentration - Financial instruments which potentially subject the Company to concentrations of credit risk are primarily accounts receivable. The Company performs ongoing credit evaluations of its customers’ financial condition. If the collection of the receivable becomes doubtful, the Company establishes a reserve in an amount determined appropriate for the perceived risk. The Company maintains its cash accounts at commercial banks. From time to time, cash balances maintained in such banks may exceed the insured amount by the Federal Deposit Insurance Corporation (FDIC). As of April 30, 2014 and July 31, 2013, management does not believe they are exposed to any significant risk on their cash balances. The Company’s products are primarily sold to global medical device companies. These customers can be significantly affected by changes in economic, competitive or other factors. The Company makes substantial sales to a relatively few, large customers, where company is seeking to capture more business from other targeted medical device companies.
	Two customers accounted for $294,000 (66%) and $150,000 (34%) of receivables at April 30, 2014 while one customer accounted for $190,000 (99%) of receivables at July 31, 2013.
	Two customers accounted for $294,000 (62%) and $150,000 (31%) of revenue for the three months ended April 30, 2014 and two customers accounted for $418,000 (60%) and $198,000 (28%) of revenue for the three months ended April 30, 2013. Three customers accounted for $1,070,200 (62%), $206,250 (12%), and $184,995 (11%) of the revenues for the nine months ended April 30, 2014 and two customers accounted for $1,428,724 (61%) and $300,000 (13%) of the revenues for the nine months ended April 30, 2013, respectively.
	Two vendors accounted for $52,000 (75%) and $8,791 (13%) of accounts payable as of April 30, 2014 and three vendors accounted for $20,000 (53%), $5,054 (13%), and $4,400 (12%) of accounts payable as of July 31, 2013, respectively.
	One vendor accounted for $178,360 (97%) of the purchases for the three months ended April 30, 2014, and three vendors accounted for $158,485 (52%), $83,800 (28%), and $47,200 (16%) of the purchases for the three months ended April 30, 2013. One vendor accounted for $708,927 (95%) of the purchases for the nine months ended April 30, 2014, and one vendor accounted for $839,209 (83%) of the purchases for the nine months ended April 30, 2013, respectively.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	RECENT ACCOUNTING PRONOUNCEMENTS
	FASB ASC Topic 220, “Compressive Income” - New authoritative accounting guidance under ASC Topic 220, “Compressive Income,” amends prior guidance to require all non-owner changes in stockholders' equity to be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Under the two-statement approach, the first statement should present total net income and its components followed consecutively by a second statement that should present total other comprehensive income, the components of other comprehensive income, and the total of comprehensive income. The pronouncement should be applied retrospectively and effective for fiscal years, and interim periods within those years, beginning after December 15, 2012. Early adoption is permitted. The adoption of this pronouncement is not expected to have a material impact on the Company's financial statements.
	FASB ASC Topic 350, “Intangible and Other Assets” - New authoritative accounting guidance under ASC Topic 350, “Intangible and Other Assets,”, which allows for an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. Under new guidance, an entity is not required to calculate the fair value of a reporting unit unless the entity determines that it is more likely than not that its fair value is less than its carrying amount. The pronouncement is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted. The adoption of this pronouncement is not expected to have a material impact on the Company's financial statements.
	Management does not believe that any other recently issued but not yet effective accounting pronouncements, if adopted, would have an effect on the accompanying consolidated financial statements.

Organization_and_Principal_Act1

Organization and Principal Activities (Tables)	9 Months Ended
	Apr. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Subsidiaries Establishment and Incorporation [Table Text Block]	'
	Details of the Company’s subsidiary as of April 30, 2014 are as follows:
	Name	Place and Date of	Relationships	Principal Activities
		Establishment/
		Incorporation
	E-Care USA, Inc.	Nevada	Wholly-owned subsidiary of AmbiCom Holdings, Inc.	Designer and developer of wireless home medical devices
		15-Mar-11

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Apr. 30, 2014
Accounting Policies [Abstract]	'
Fair Value, by Balance Sheet Grouping [Table Text Block]	'
	The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments at:
		April 30, 2014				July 31, 2013
		Carrying		Fair value		Carrying		Fair value
		amount				amount
	Financial assets:
	Cash and cash equivalents	$	249,212	$	249,212	$	596,871	$	596,871
	Accounts receivable	$	445,640	$	445,640	$	191,835	$	191,835
	Financial liabilities:
	Accounts payable and accrued liabilities	$	94,958	$	94,958	$	62,810	$	62,810
	Auto loan	$	77,894	$	71,651		0		0
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'
	The following table presents the placement in the fair value hierarchy of assets and liabilities that are measured at fair value on a recurring basis at:
				Fair value measurements at
				reporting date using
		April 30,		Quoted prices		Significant		Significant
		2014		in active		other		unobservable
				markets for		observable		inputs
				identical		inputs		(Level 3)
				assets		(Level 2)
				(Level 1)
	Notes payable	77,894						71,650
				Fair value measurements at
				reporting date using
		31-Jul-13		Quoted prices		Significant		Significant
				in active		other		unobservable
				markets for		observable		inputs
				identical		inputs		(Level 3)
				assets		(Level 2)
				(Level 1)
	Notes payable	0						0

Property_and_Equipment_Tables

Property and Equipment (Tables)	9 Months Ended
	Apr. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
		April 30, 2014		July 31, 2013
	Furniture and fixture	$	27,634	$	27,634
	Machinery and equipment		27,540		26,305
	Software		359,417		359,417
	Leasehold Improvements		5,985		5,985
	Vehicle		105,278		-
			525,854		419,341
	Accumulated depreciation		-421,815		-404,140
	Property and equipment, net	$	104,039	$	15,201

Note_Payable_Tables

Note Payable (Tables)	9 Months Ended
	Apr. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Debt [Table Text Block]	'
	Note Payable Consist of the Following at:
		April 30, 2014		July 31, 2013
	Note payable to Bank of America, Auto Loan	$	77,894	$	-
	Total note payable		77,894		-
	Less current portion		15,688
	Long-term note payable	$	62,206	$	-

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	9 Months Ended
	Apr. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]	'
	The minimum rental commitments under the lease are as follows:
	Year Ending July 31:
	2014	$	14,352
	2015		58,007
	2016		49,537
	Total	$	121,896

Organization_and_Principal_Act2

Organization and Principal Activities (Details) (E-Care USA, Inc. [Member])	9 Months Ended
	Apr. 30, 2014
E-Care USA, Inc. [Member]	'
Subsidiaries Establishment And Incorporation [Line Items]	'
Entity Incorporation, Date of Incorporation	15-Mar-11
Entity Incorporation, State Country Name	'Nevada
Relationship Subsidiary	'Wholly-owned subsidiary of AmbiCom Holdings, Inc.
Subsidiary Or Equity Method Investee Principal Activities	'Designer and developer of wireless home medical devices

Organization_and_Principal_Act3

Organization and Principal Activities (Details Textual) (USD $)	0 Months Ended
	Jan. 15, 2010	Apr. 30, 2014	Jul. 31, 2013
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'	'	'
Initial Shares Authorized	75,000,000	'	'
Shares Authorized After Amendment of Articles of Incorporation	1,050,000,000	'	'
Common Stock, Shares Authorized	'	125,000,000	125,000,000
Stockholders' Equity Note, Stock Split	'forward-split such that 131.2335958 shares of Common Stock were issued for every 1 share of Common Stock	'	'
Stockholders Equity Note, Stock Split, Conversion Ratio	131.2335958	'	'
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	20,000,000	'	'
Business Combination, Options Issued to Acquire Entity Exercise Price (in dollars per share)	$0.01	'	'
Business Combination, Warrants Issued to Acquire Entity, Number of Securities Called by Warrants or Rights	500,000	'	'
Business Combination, Warrants Issued to Acquire Entity Exercise Price (in dollars per share)	$0.50	'	'
Common Stock Price Value Per Share at Closing of the Offering (in dollars per share)	$0.40	'	'
Aggregate Common Stock Shares at Closing of Offering	1,250,000	'	'
Common Stock Aggregate Offering Price Value (in dollars)	$500,000	'	'
Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation	6,000,000	'	'
Equity Method Investment, Ownership Percentage	55.00%	'	'
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions	76.00%	'	'
Series A Preferred Stock [Member]	'	'	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'	'	'
Preferred Stock, Shares Authorized	'	10,000,000	10,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	'	0.001	0.001
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	2,350,000	'	'
Series B Preferred Stock [Member]	'	'	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'	'	'
Preferred Stock, Shares Authorized	'	325,000	325,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	'	0.008	0.008
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	2,600,000	'	'
Common Stock [Member]	'	'	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'	'	'
Common Stock, Shares Authorized	1,000,000,000	'	'
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	5,500,000	'	'
Preferred Stock [Member]	'	'	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'	'	'
Preferred Stock, Shares Authorized	50,000,000	'	'
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$0.00	'	'

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details) (USD $)	Apr. 30, 2014	Jul. 31, 2013	Apr. 30, 2013	Jul. 31, 2012
Financial assets, Carrying amount:	'	'	'	'
Cash and cash equivalents, Carrying amount	$249,212	$596,871	$688,299	$249,327
Accounts receivable, Carrying amount	445,640	191,835	'	'
Financial liabilities, Carrying amount:	'	'	'	'
Accounts payable and accrued liabilities, Carrying amount	94,958	62,810	'	'
Auto loan, Carrying amount	77,894	0	'	'
Financial assets, Fair value:	'	'	'	'
Cash and cash equivalents, Fair value	249,212	596,871	'	'
Accounts receivable, Fair value	445,640	191,835	'	'
Financial liabilities, Fair value:	'	'	'	'
Accounts payable and accrued liabilities, Fair value	94,958	62,810	'	'
Auto loan, Fair value	$71,651	$0	'	'

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Details 1) (USD $)	Apr. 30, 2014	Jul. 31, 2013
Fair Value Hierarchy Of Assets And Liabilities [Line Items]	'	'
Notes payable	$77,894	$0
Fair Value, Inputs, Level 1 [Member]	'	'
Fair Value Hierarchy Of Assets And Liabilities [Line Items]	'	'
Notes payable	'	'
Fair Value, Inputs, Level 2 [Member]	'	'
Fair Value Hierarchy Of Assets And Liabilities [Line Items]	'	'
Notes payable	'	'
Fair Value, Inputs, Level 3 [Member]	'	'
Fair Value Hierarchy Of Assets And Liabilities [Line Items]	'	'
Notes payable	$71,650	$0

Summary_of_Significant_Account5

Summary of Significant Accounting Policies (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013	Jul. 31, 2013
Accounting Policies [Line Items]	'	'	'	'	'
Allowance for Doubtful Accounts Receivable, Current (in dollars)	$26	'	$26	'	$26
Inventory Valuation Reserves (in dollars)	7,551	'	7,551	'	10,360
Vendor 1 [Member]	'	'	'	'	'
Accounting Policies [Line Items]	'	'	'	'	'
Entity Wide Accounts Payable, Major Supplier Amount (in dollars)	52,000	'	52,000	'	20,000
Entity Wide Accounts Payable, Major Percentage	75.00%	'	75.00%	'	53.00%
Entity Wide Purchase, Major Supplier, Amount (in dollars)	178,360	158,485	708,927	839,209	'
Entity Wide Purchase, Major Supplier, Percentage	97.00%	52.00%	95.00%	83.00%	'
Vendor 2 [Member]	'	'	'	'	'
Accounting Policies [Line Items]	'	'	'	'	'
Entity Wide Accounts Payable, Major Supplier Amount (in dollars)	8,791	'	8,791	'	5,054
Entity Wide Accounts Payable, Major Percentage	13.00%	'	13.00%	'	13.00%
Entity Wide Purchase, Major Supplier, Amount (in dollars)	'	83,800	'	'	'
Entity Wide Purchase, Major Supplier, Percentage	'	28.00%	'	'	'
Vendor3 [Member]	'	'	'	'	'
Accounting Policies [Line Items]	'	'	'	'	'
Entity Wide Accounts Payable, Major Supplier Amount (in dollars)	'	'	'	'	4,400
Entity Wide Accounts Payable, Major Percentage	'	'	'	'	12.00%
Entity Wide Purchase, Major Supplier, Amount (in dollars)	'	47,200	'	'	'
Entity Wide Purchase, Major Supplier, Percentage	'	16.00%	'	'	'
Customer 1 [Member]	'	'	'	'	'
Accounting Policies [Line Items]	'	'	'	'	'
Accounts Receivables from Customers (in dollars)	294,000	'	294,000	'	190,000
Entity Wide Receivable, Customer, Percentage	66.00%	'	66.00%	'	99.00%
Entity-Wide Revenue, Major Customer, Amount (in dollars)	294,000	418,000	1,070,200	1,428,724	'
Entity Wide Revenue Major Customer Percentage	62.00%	60.00%	62.00%	61.00%	'
Customer 2 [Member]	'	'	'	'	'
Accounting Policies [Line Items]	'	'	'	'	'
Accounts Receivables from Customers (in dollars)	150,000	'	150,000	'	'
Entity Wide Receivable, Customer, Percentage	34.00%	'	34.00%	'	'
Entity-Wide Revenue, Major Customer, Amount (in dollars)	150,000	198,000	206,250	300,000	'
Entity Wide Revenue Major Customer Percentage	31.00%	28.00%	12.00%	13.00%	'
Customer 3 [Member]	'	'	'	'	'
Accounting Policies [Line Items]	'	'	'	'	'
Entity-Wide Revenue, Major Customer, Amount (in dollars)	'	'	$184,995	'	'
Entity Wide Revenue Major Customer Percentage	'	'	11.00%	'	'

Liquidity_and_Shareholders_Equ1

Liquidity and Shareholders' Equity (Details Textual) (USD $)

9 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

Apr. 30, 2014

Apr. 30, 2013

Jul. 31, 2013

Jul. 31, 2012

Sep. 30, 2011

Jul. 31, 2011

Apr. 30, 2014

Jul. 31, 2013

Sep. 30, 2011

Apr. 30, 2014

Apr. 30, 2014

Jul. 31, 2013

Apr. 30, 2014

Jul. 31, 2013

Apr. 30, 2014

Apr. 30, 2014

Apr. 30, 2014

Apr. 30, 2014

Apr. 30, 2014

Sep. 01, 2010

Apr. 30, 2014

1-May-12

Apr. 30, 2014

Apr. 30, 2014

Sep. 01, 2012

Apr. 30, 2014

Apr. 30, 2014

Jan. 15, 2014

Apr. 30, 2014

Apr. 30, 2014

Dec. 31, 2013

Apr. 30, 2014

Jul. 31, 2013

Jul. 31, 2011

Jul. 31, 2011

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Equity Incentive Plans 2010 [Member]

Series A Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Before Amendment [Member]

Before Amendment [Member]

After Amendment [Member]

After Amendment [Member]

After Amendment [Member]

Common Stock Issuance One [Member]

Common Stock Issuance Two [Member]

Common Stock Issuance Three [Member]

Common Stock Issuance Four [Member]

Eight Employees [Member]

Eight Employees [Member]

Two Employees [Member]

Two Employees [Member]

Two Employees [Member]

Two Employees 1 [Member]

Two Employees 1 [Member]

Two Employees 1 [Member]

Four Employees [Member]

Four Employees [Member]

Four Employees [Member]

Before Amendment [Member]

After Amendment [Member]

Stockholders' Equity Note [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash and Cash Equivalents, at Carrying Value (in dollars)

$249,212

$688,299

$596,871

$249,327

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Working Capital, at Carrying Value (in dollars)

730,288

'

600,922

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Authorized

'

'

'

'

'

'

'

'

'

50,000,000

10,000,000

10,000,000

325,000

325,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,000,000

'

'

'

'

Preferred Stock, Shares Outstanding

'

'

'

'

'

'

'

'

'

'

7,050,000

7,050,000

262,475

262,475

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

262,475

262,475

2,600,000

325,000

Preferred Stock, Par or Stated Value Per Share (in dollars per share)

'

'

'

'

'

'

'

'

'

$0.00

$0.00

$0.00

$0.01

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.00

$0.01

Common Stock, Dividend Rate, Percentage

'

'

'

'

'

'

'

'

'

'

'

'

6.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares, Issued

11,442,473

'

11,442,473

'

1,000,000,000

'

'

'

125,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares, Outstanding

10,806,520

'

10,806,520

'

'

52,577,445

11,442,473

10,806,520

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Par or Stated Value Per Share (in dollars per share)

$0.01

'

$0.01

'

$0.00

'

'

'

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversation Rate Preferred Stock (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

$1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversation Rate Preferred Stock Year Two (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

$0.40

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversation Rate Preferred Stock Year Two Weighted Average Price Percentage

'

'

'

'

'

'

'

'

'

'

'

'

70.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Redemption Date

'

'

'

'

'

'

'

'

'

'

'

'

31-Dec-15

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Redemption Price Per Share (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

$1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock Liquidation Preference Value (in dollars)

'

'

'

'

'

'

'

'

'

'

'

'

2,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Exercise Price of Options, Description

'the exercise price of options granted shall be not less than 110% of the average of the closing price for the 30 days preceding the grant date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Capital Shares Reserved for Future Issuance

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,277,778

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

840,000

'

250,000

'

'

75,000

'

'

305,000

'

'

'

'

'

'

'

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.20

'

$0.09

'

'

$0.03

'

'

$0.16

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.79%

'

1.79%

'

'

1.59%

'

'

2.87%

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

40.00%

'

40.00%

'

'

67.00%

'

'

72.00%

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'10 years

'

'10 years

'

'

'10 years

'

'

'10 years

'

'

'

'

'

'

'

Share-based Compensation (in dollars)

$9,818

$7,106

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$446

'

$732

$2,196

'

$381

$1,144

'

$4,524

$6,032

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding

343,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

250,000

250,000

75,000

305,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.20

$0.09

$0.03

$0.16

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant

807,778

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	Apr. 30, 2014	Jul. 31, 2013
Property, Plant and Equipment [Line Items]	'	'
Furniture and fixture	$27,634	$27,634
Machinery and equipment	27,540	26,305
Software	359,417	359,417
Leasehold Improvements	5,985	5,985
Vehicle	105,278	0
Property, Plant and Equipment, Gross	525,854	419,341
Accumulated depreciation	-421,815	-404,140
Property and equipment, net	$104,039	$15,201

Property_and_Equipment_Details1

Property and Equipment (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Property, Plant and Equipment [Line Items]	'	'	'	'
Property, Plant and Equipment, Estimated Useful Lives	'	'	'	'the life of the current facility lease
Depreciation	$6,488	$1,578	$17,675	$4,698
Furniture and Fixtures [Member]	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'
Property, Plant and Equipment, Estimated Useful Lives	'	'	'	'seven years
Machinery and Equipment [Member]	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'
Property, Plant and Equipment, Estimated Useful Lives	'	'	'	'five years
Software [Member]	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'
Property, Plant and Equipment, Estimated Useful Lives	'	'	'	'five years

Revolving_Line_of_Credit_Detai

Revolving Line of Credit (Details Textual) (USD $)	9 Months Ended
	Apr. 30, 2014
Debt Disclosure [Line Items]	'
Line of Credit Facility, Interest Rate Description	'advances under the credit line were secured with substantially all of the Company’s assets, were subject to interest at 1% above the Wall Street Journal prime rate index
Line of Credit Facility, Interest Rate Requirements, Current Ratio, Minimum	'1.2 times
Line of Credit Facility, Interest Rate Requirements, Debt to Tangible Net Worth Ratio, Maximum	'2.5 times
Line of Credit Facility, Quarterly EBITDA on Rolling Four Quarter Basis, Minimum (in dollars)	$30,000

Note_Payable_Details

Note Payable (Details) (USD $)	Apr. 30, 2014	Jul. 31, 2013
Notes Payable Unsecured Disclosure [Line Items]	'	'
Note payable to Bank of America, Auto Loan	$77,894	$0
Total note payable	77,894	0
Less current portion	15,688	0
Long-term note payable	$62,206	$0

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Apr. 30, 2014
Income Tax Disclosure [Line Items]	'
Operating Loss Carryforwards (in dollars)	$2.16
Operating Loss Due Date	'2018

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	Apr. 30, 2014
Future Minimum Lease Payments for Capital Leases [Line Items]	'
2014	$14,352
2015	58,007
2016	49,537
Total	$121,896

Commitments_and_Contingencies_2

Commitments and Contingencies (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Commitments and Contingencies Disclosure [Line Items]	'	'	'	'
Rent Expenses	$13,419	$13,419	$40,256	$40,256
Lease Expiration Date	'	'	31-May-16	'

Subsequent_Events_Details_Text

Subsequent Events (Details Textual) (USD $)	Apr. 30, 2014	Jul. 31, 2013	Apr. 30, 2014
			Subsequent Event [Member]
			Veloxum Corp [Member]
Subsequent Event [Line Items]	'	'	'
Subsequent Event, Date	'	'	1-May-14
Common Stock, Par or Stated Value Per Share	$0.01	$0.01	$0.01
Common Stock, Value, Issued	$91,537	$86,449	$3,000,000
Common Stock, Shares, Issued	11,442,473	11,442,473	13,100,437